Browsing by Subject "Imatinib mesylate"
Now showing items 1-1 of 1
-
(Sociedad Médica de Santiago, 2020)Hypophosphatemia is a relatively frequent and a potentially serious adverse drug effect. Clinically it is characterized by bone pain and muscle weakness. There are several mechanisms by which a drug can induce hypophosphatemia ...